idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
idw - Informationsdienst
Wissenschaft
Researchers reveal that lung cancer cells form direct synapses with neurons to grow and proliferate, opening the door to new therapies that cut the communication lines / publication in ”Nature”
An international research team has shown that lung cancer cells can form functional synapses with neurons, effectively hijacking the body’s neural circuits to grow faster. The finding reveals a startling new dimension of cancer biology and opens promising new avenues for therapies against this disease. The study titled “Functional synapses between neurons and small-cell lung cancer” was published in Nature.
Previously, synapses had only been seen in brain tumours, which arise from the nervous system itself. Finding that a lung cancer can wire itself into neural circuits reveals how deeply a tumour can integrate with the host to survive and thrive. “Our study underscores the alarming extent to which the organism can communicate with and nurture a tumour, supporting its growth as if it were a healthy tissue,” said Dr Filippo Beleggia, from the Department of Translational Genomics, who coordinated the study.
Starting from the analysis of genetic data, the researchers identified a set of genes involved in synaptic formation and went on to visualize the presence of synapses between small cell lung cancer (SCLC) cells and neurons in cell culture and in mouse models. “I was stunned to see the extent of innervation that SCLC cells manage to co-opt,” said senior and co-corresponding author Professor Dr Matteo Bergami, Principal Investigator at the University of Cologne’s CECAD Cluster of Excellence for Aging Research. “I believe that these findings can become transformative for the development of more efficient therapies to prevent SCLC from metastasizing to the brain.”
The researchers detected neuron-to-cancer synaptic communication through two different neurotransmitters: glutamate and GABA. They further found that SCLC cells proliferated faster in the presence of sensory or cortical neurons. “By forming synaptic connections with different types of neurons, SCLC cells reveal an impressive adaptability to boost their growth,” said Dr Elisa Motori from the Institute of Biochemistry, one of the senior and co-corresponding authors. “It is tempting to speculate that SCLC cells are not only ‘chatting’ with neurons but are also receiving resources from them to support their growth.”
Crucially, disrupting glutamate signalling led to lower tumour burden and longer survival of the experimental mice, highlighting promising new targets for cancer therapy. “Our observations may open a path forward for the implementation of novel therapeutic interventions in SCLC,” said lead corresponding author Professor Christian Reinhardt from the West German Cancer Center at the University Hospital Essen. “We have shown that pharmacological disruption of the cancer–neuron crosstalk leads to improved tumour control and that such treatments can be combined with chemotherapy.”
The large international collaboration was led by the laboratories of Dr Filippo Beleggia (University of Cologne), Professor Dr Christian Reinhardt (University Hospital Essen), Dr Elisa Motori (University of Cologne), Professor Dr Matteo Bergami (University of Cologne), Professor Dr Silvio Rizzoli (University of Göttingen) and Professor Dr Max Anstötz (Heinrich Heine University Düsseldorf), with key partners in Cologne, Munich, Antwerp and Stanford.
These discoveries suggest several therapeutic possibilities, from repurposing existing neurotransmitter-blocking drugs to developing entirely new approaches targeting cancer–neuron communication. The research team continues to investigate the molecular details of these synaptic connections, work that will be essential for optimizing treatment strategies and identifying the most promising therapeutic combinations.
The research was primarily supported by the German Cancer Aid (Deutsche Krebshilfe) and by the German Research Foundation (DFG) through Collaborative Research Centre 1399 – Mechanisms of Drug Sensitivity and Resistance in Small Cell Lung Cancer. The project also received generous support from a wide range of national and international funding agencies, including the Boehringer Ingelheim Stiftung. A full list is available in the published paper.
Dr Filippo Beleggia
Department of Translational Genomics, University of Cologne
+49 221 478 96703
filippo.beleggia@uk-koeln.de
Dr Elisa Motori
Institute of Biochemistry, University of Cologne
+49 221 478 15343
elisa.motori@uni-koeln.de
https://www.nature.com/articles/s41586-025-09434-9
Electron micrograph of mouse brain SCLC allograft showing a synaptic contact between cancer cell (re ...
Source: Chihab, Ndoci und Gaedke
Copyright: Universität zu Köln
Criteria of this press release:
Journalists, Scientists and scholars
Biology, Medicine
transregional, national
Research results
English
You can combine search terms with and, or and/or not, e.g. Philo not logy.
You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).
Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.
You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).
If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).
